The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...
AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.
If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...